ForteBio, Inc. Acquired by Pall Corporation

December 21, 2011 -- ForteBio, a venture backed company that makes instruments for biotech drug development, was acquired by Pall Corporation for an undisclosed sum. ForteBio produces systems that enable real-time analysis of biomolecular interactions. Based in Menlo Park, Forte has a wholly-owned manufacturing subsidiary in Shanghai's Zhangjiang Hi-Tech Park. More details....

Stock Symbol: (NYSE: PLL)

Back to news